News Feeds - Natraderm Skin Treatment

Health News Feeds
Women's Health / Gynecology News From Medical News Today
Latest Women's Health / Gynecology News From Medical News Today.
Denver Post Examines Outlook For Embryonic Stem Cell Research Policy Shift With Next President The Denver Post on Wednesday examined possible changes to federal funding for human embryonic stem cell research with the next president. According to the Post, stem cell research in the U.S. is "likely to get a fresh look" from the next president, "no matter who it is. 'Telepsychiatry' Allows Nurses To Treat Women With Postpartum Depression Women suffering with postpartum depression may in future be able to receive psychotherapy from a specially trained nurse over the phone, eliminating barriers to treatment such as distance, time or the availability of a psychologist or psychiatrist.Professor Cindy-Lee Dennis, Canada Research Chair in Perinatal Community Health at U of T's Lawrence S. Opponents Of Colo. Ballot Proposal Warn Against Unintended Consequences For Physicians, Women A coalition of opponents against a Colorado ballot initiative that would define a fertilized embryo as a person and extend to it rights and protections under the state constitution said Tuesday that the amendment could lead to a range of unintended consequences for women and doctors in the state, the AP/Denver Post reports. BiPar Sciences Expands Phase 2 Clinical Trials Of BSI-201, A Novel DNA Repair Inhibitor, In Ovarian Cancer BiPar Sciences, Inc. announced the expansion of Phase 2 clinical trial programs for its lead product, BSI-201, in ovarian cancer. This is the third major clinical trial of BSI-201 that BiPar has launched in the past 6 months, expanding on on going trials in breast and brain cancer. Patients, Doctors, Pharmacists Praise Bipartisan House Resolution On Compounded Hormones Containing Estriol The International Academy of Compounding Pharmacists joined hundreds of thousands of women and doctors in applauding the introduction of H. Con. Res. 342, a bipartisan resolution stating that "the Food and Drug Administration's (FDA) new policy restricting women's access to medications containing estriol does not serve the public interest" and calling on the FDA to "reverse its policy." Reps. Mike Ross (D-Ark.), Jo Ann Emerson (R-Mo.), Sam Farr (D-Calif. Appropriate Treatment Methods Can Prevent Nearly All Risk Of Mother-To-Child HIV Transmission, Study Says Providing appropriate treatment methods to HIV-positive women during pregnancy can prevent nearly all risk of mother-to-child transmission of the virus, according to a study published online Wednesday in the journal AIDS, the PA/Google.com reports (Kirby, PA/Google.com, 5/6). AFP/Google.com Examines Use Of Surrogate Mothers Among Gay Male Couples AFP/Google.com on Tuesday examined the increasing number of gay male couples who are having children through surrogacy services. According to AFP/Google.com, the number of gay couples in the U.S. who have children through surrogacy or adoption is increasing. The Wal-Mart Adds Prescription Women's Health Medications To Discount Drug Program Wal-Mart Stores on Monday announced that it is adding several women's health-related medications to its discounted prescription drug program, the Wall Street Journal reports. Wal-Mart pharmacies will provide $9 generic prescriptions for up to 30-day supplies of several drugs that treat breast cancer, hormone deficiency, menopause and osteoporosis (Zimmerman, Wall Street Journal, 5/6). Bonaventura Reproductive Medicine To Offer Pioneering Test Of A Woman's Biological Clock Bonaventura Reproductive Medicine announced it will offer the Repromedix's PlanAhead test, an innovative blood test that provides an assessment of a woman's egg supply by combining multiple factors including the measurement of ovary-related hormones AMH, Inhibin B, and FSH. The window of opportunity for a woman to have children by natural conception is dependent upon an adequate supply of eggs, which inevitably declines as a woman ages and her "biological clock ticks. National Community Pharmacists Association Statement On "Sense Of Congress" Resolution Opposing FDA Restrictions On Estriol Usage Yesterday H. Con. Res. 342 was introduced by Rep. Mike Ross (D-Ark.) and Jo Ann Emerson (R-Mo.) opposing the Food and Drug Administration's (FDA) decision to restrict Estriol (a form of Estrogen), a compounded hormone preparation used by women to alleviate the symptoms of menopause. The action was taken after the FDA sent letters to seven pharmacies in January asking them to cease and desist with the use of estriol.

[ Back ]